136
Participants
Start Date
January 14, 2025
Primary Completion Date
January 31, 2030
Study Completion Date
January 31, 2030
Cemiplimab
Cemiplimab is provided in a 10 ml glass vial
Placebo
standard saline solution
RECRUITING
Cliniques Universitaires Saint-Luc, Brussels
RECRUITING
CHU Helora Pole Hospitalier Jolimont, Haine-Saint-Paul
NOT_YET_RECRUITING
CHU Mont Godinne - UCL Namur, Yvoir
RECRUITING
CH de La Cote Basque - Saint Leon, Bayonne
NOT_YET_RECRUITING
Institut Paoli-Calmettes, Marseille
NOT_YET_RECRUITING
Groupe Hospitalier Paris Saint Joseph, Paris
NOT_YET_RECRUITING
ASST Ovest Milanese - Legnano, Legnano
RECRUITING
Azienda Unita Locale Socio-Sanitaria N. 9-Mater Salutis Hospital, Legnano
NOT_YET_RECRUITING
Fondazione IRCCS - Policlinico San Matteo, Pavia
NOT_YET_RECRUITING
AUSL Della Romagna - Ospedale Santa Maria delle Croci, Ravenna
NOT_YET_RECRUITING
Istituto Clinico Humanitas, Rozzano
NOT_YET_RECRUITING
"Azienda Ospedaliero - Universitaria Santa Maria della Misericordia di Udine", Udine
RECRUITING
Academisch Ziekenhuis Maastricht, Maastricht
RECRUITING
Hospital De La Santa Creu I Sant Pau, Barcelona
RECRUITING
UOMi Cancer Center, Barcelona
RECRUITING
Hospital Quironsalud Sagrado Corazon, Seville
RECRUITING
University Hospital Virgen del Rocio, Seville
European Organisation for Research and Treatment of Cancer - EORTC
NETWORK